Carnamedicasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-05-30
Share capital
10 000,00 PLN
Activity description

Carnamedica manufactures EU-made equipment for organ procurement, including perfusion solutions and CE-marked class III cold-storage products. Its range includes perfusion lines, organ procurement cannulas in sizes from 8F to 25F, and other medical devices for transplantation; production takes place in a GMP-certified factory.

Registered address
ul. Olszynki Grochowskiej 21/U6, 04-281 Warszawa, Poland
Website
carnamedica.com
Opening hours
Monday–Friday
9:00–17:00
Saturday
9:00–13:00
Email
Phone
Electronic delivery address
AE:PL-78419-99720-FCCBD-24

Financials

Revenue history (in m)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 129 days for 2023). 2 of 6 audited by a statutory auditor.

  • 202514/07/2026
  • 202420/06/2025
  • 202321/11/2024
  • 202215/09/2023
  • 202110/08/2022
  • 202024/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 10.63mMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 3.79mMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 5.92mMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 12.16mMedianUSD 609.79kAverageUSD 11.85m

Industry

Offer

  • Perfusion solutions
  • Organ preservation fluids
  • Perfusion sets
  • Organ procurement cannulas
  • Medical devices for transplantation
Certifications: GMP

Website technology

Online shop
  • WooCommerce
Website
  • WordPress
  • Elementor

Public procurement

12 tenders recorded as contractor: 1 national ($102,661) and 11 EU ($11,766,835).

SubjectAmount
Successive supply of infusion fluids, enteral and parenteral nutrition products, and selected medicinal products
$183.3K
Successive supply of infusion fluids, enteral and parenteral nutrition products, and selected medicinal products
$183.3K
Purchase and supply of a medical product - Custodiol
$102.7K

Authorized Representatives

Jerzy Jacek Markowski – Management Board Member
Paweł Marek Szczudło – Management Board Member

Manner of representation

Each member of the management board is entitled to represent the company independently.

Ownership

OwnerSharesShare valueStake
Jerzy Jacek Markowskiage 42
10$270.1210%
Paweł Marek Szczudłoage 55
90$2,431.1290%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-05-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

7 public aid cases recorded, with a total value of $1,062,778.

PurposeGross amount
Aid for research and development projects: experimental development
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

European Funds

ProjectEU co-financing
Energy-efficient production of lung transplant fluids
$493.8K
Development and testing of improved fluids for short- and long-term cell storage
$530.7K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Camedica Paweł Harasimiuksp. k.
Domesthicsp. z o.o.
Medicomsp. z o.o.
Wellmedica Hfsp. z o.o.
Mscdsp. z o.o.
Biochem PolskaS.A.
Mindray Medical Polandsp. z o.o.
Polmilsp. z o.o.
Polimed Researchsp. z o.o.
Medaccesssp. z o.o.

Change history

DateEvent
2020-10-06PKD change
2016-12-07Address change
2016-05-30Entered in the register

FAQ

Last updated: 2026-10-27